Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Ascent
FDA Approves HYDROMORPHONE HYDROCHLORIDE — Ascent Pharmaceuticals Inc

Ascent Pharmaceuticals Inc. received FDA approval for the ANDA210506 of Hydromorphone Hydrochloride Tablets, offering a potential additional oral gene...

Fresenius
FDA Approves REMIFENTANIL HYDROCHLORIDE — Fresenius Kabi USA, LLC

Fresenius Kabi USA announced the spread of the 50 mg/RBC units FDA approval for remifentanil hydrochloride injections, removing a regulatory hurdle th...

AMNEAL
FDA Approves Unknown Drug — AMNEAL PHARMS

# FDA Approves Generic Drug Application for Amneal Pharmaceuticals Amneal Pharmaceuticals received FDA approval for ANDA210040 on December 22, 2017, ...

Aeterna
FDA Approves MACRILEN — Aeterna Zentaris GmbH

On December 20, 2017, the FDA approved macimorelin (Macrilen), developed by Aeterna Zentaris GmbH, marking a significant milestone as the first endoge...

Merck
FDA Approves STEGLUJAN — Merck Sharp & Dohme LLC

# FDA Approves Merck's STEGLUJAN Combination Therapy for Type 2 Diabetes Merck Sharp & Dohme LLC received FDA approval for STEGLUJAN (ertugliflozin a...

Merck
FDA Approves STEGLATRO — Merck Sharp & Dohme LLC

# FDA Approves Merck's STEGLATRO (Ertugliflozin) for Type 2 Diabetes Merck Sharp & Dohme LLC received FDA approval for STEGLATRO (ertugliflozin), an ...

Merck
FDA Approves SEGLUROMET — Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC received FDA approval on Dec. 19, 2017, for Segluromet, a fixed-dose tablet containing ertugliflozin and metformin, which is p...

Eugia
FDA Approves ZOLEDRONIC ACID — Eugia US LLC

# FDA Approves Generic Zoledronic Acid Intravenous Formulation Eugia US LLC has received FDA approval for its generic zoledronic acid intravenous for...

Novo
FDA Approves OZEMPIC — Novo Nordisk Pharmaceutical Industries, LP

# FDA Approves Novo Nordisk's Ozempic for Type 2 Diabetes Treatment Novo Nordisk Pharmaceutical Industries, LP received FDA approval for Ozempic (sem...

ZHEJIANG
FDA Approves Unknown Drug — ZHEJIANG HISUN PHARM

Zhejiang Hisun Pharm has received FDA approval for the generic version of S Combipres (ncludpril & clonidine) indicated for hypertension, securing a s...

AstraZeneca
FDA Approves FASENRA — AstraZeneca Pharmaceuticals LP

AstraZeneca announced on November 14, 2017, that the FDA granted full approval for its blockbuster respiratory drug FASENRA, the subcutaneous formulat...

ZHEJIANG
FDA Approves Unknown Drug — ZHEJIANG HISUN PHARM

Zhejiang Hisun Pharmaceutical has received FDA approval for its ANDA 204077, a pivotal move that sets the stage for commercial entry into the U.S. mar...

AstraZeneca
FDA Approves CALQUENCE — AstraZeneca Pharmaceuticals LP

# FDA Approves AstraZeneca's CALQUENCE (acalabrutinib) for Blood Cancer Treatment AstraZeneca Pharmaceuticals LP received FDA approval for CALQUENCE ...

Eywa
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Eywa Pharma Inc

Eywa Pharma Inc secured FDA approval for its ANDA 210211 covering Hydrocodone Bitartrate and Acetaminophen oral tablets, thereby granting the company ...

Ascent
FDA Approves HYDROMORPHONE HYDROCHLORIDE — Ascent Pharmaceuticals Inc

1. **Analyze the Request:** * **Topic:** FDA drug approval (generic hydromorphone hydrochloride). * **Key Data:** * Brand/Subst...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS ELIZABETH

Actavis Elizabeth announced the approval of its abbreviated new drug application [INSERT GENERIC NAME] by the FDA, marking a significant entry for the...

Amneal
FDA Approves ISOTRETINOIN — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals has announced the launch of isotretinoin, completing FDA approval following the filing of ANDA 207792. This entry into the mark...

LANNETT
FDA Approves Unknown Drug — LANNETT CO INC

On September 25, 2017, Lannett Company received FDA approval for a generic drug indicated by ANDA207333, positioning the company for potential market ...

Actelion
FDA Approves TRACLEER — Actelion Pharmaceuticals US, Inc.

# FDA Approves Actelion Pharmaceuticals' TRACLEER (bosentan) Oral Formulation Actelion Pharmaceuticals US, Inc. received FDA approval for TRACLEER (b...

ZYDUS
FDA Approves Unknown Drug — ZYDUS PHARMS

Zydus Pharmaceuticals has received approval from the Food and Drug Administration (FDA) for ANDA 204473, marking a strategic entry into the market tha...